Quantcast

Latest Regenerative medicine Stories

2014-09-30 16:28:42

MARIETTA, Ga., Sept. 30, 2014 /PRNewswire/ -- MiMedx Group, Inc. (NASDAQ: MDXG), the leading regenerative medicine company utilizing human amniotic tissue and patent-protected processes to develop and market advanced products and therapies for the Wound Care, Surgical, Orthopedic, Spinal, Sports Medicine, Ophthalmic and Dental sectors of healthcare, announced today that Dr. Tom Koob, Ph.D., Chief Scientific Officer, will present at the Stem Cell Meeting on the Mesa. Dr. Koob will...

2014-09-30 08:31:55

ST. LOUIS, Sept. 30, 2014 /PRNewswire/ -- ISTO Technologies, Inc., a privately-held regenerative medicine company, announced today announced that Mitchell Seyedin, Ph.D., the Company's Executive Chairman, will present at the 4th Annual Partnering Forum, part of the Stem Cell Meeting on the Mesa, as follows: Event: 2014 Stem Cell Meeting on the Mesa - Partnering Forum Date: October 7, 2014 Time: 11:15 am PDT Location:...

2014-09-29 16:25:42

Cartilage Symposium Host to Lively Debate, Lab Demonstrations VIRGINIA BEACH, Va., Sept. 29, 2014 /PRNewswire-USNewswire/ -- Ten of the most highly-respected physicians and scientists from the fields of cartilage repair, regeneration, allograft reconstruction and research and development, as well as attendees from around the world gathered to discuss the future of cartilage regeneration at the 2014 LifeNet Health Institute of Regenerative Medicine symposium, Cartilage Regeneration: State of...

2014-09-25 23:10:50

A year after its formation in September 2013, Boston’s Adult Stem Cell Technology Center, LLC (ASCTC) was invited to present its commercialization plans and progress at the 7th Annual BioPharm America™ International Partnering Conference held in Boston from September 22-24. Over the three-day conference, the ASCTC presented to pharmaceutical executives and pharmaceutical investors its one-of-a-kind technologies poised to revolutionize stem cell medicine. Boston, Massachusetts (PRWEB)...

2014-09-24 12:30:01

PALM HARBOR, Fla., Sept. 24, 2014 /PRNewswire/ -- The Palo Alto Longevity Prize is a $1 million life science competition that challenges teams from all over the world to extend life spans. For more information log on to www.PaloAltoPrize.com. Regenerative Processing Plant, LLC (RPP) has accepted this ambitious challenge and has registered their intent to participate. In a recent study, Harvard scientists found a protein that could reverse the aging process; May 2014, the Harvard...

2014-09-23 08:29:34

President-Elect of the Society for Cryobiology and Former Cell Therapy Executive Join Leading Clinicians, Developers, and Consultants in the Biobanking, Drug Discovery, and Regenerative Medicine Markets BOTHELL, Wash., Sept. 23, 2014 /PRNewswire/ -- BioLife Solutions, Inc. (NASDAQ: BLFS), a leading developer, manufacturer and marketer of proprietary clinical grade hypothermic storage and cryopreservation freeze media and precision thermal shipping products for cells and tissues ("BioLife" or...

2014-09-17 16:25:43

LONDON, Sept. 17, 2014 /PRNewswire/ -- U.S. National Institute of Health stated that regenerative medicine is the process of creating functional tissue to repair and replace tissue or organ which has lost their function due to damage, congenital defects, disease and age. Moreover, it has included stem cell therapy, tissue engineering and biomaterial under the umbrella of regenerative medicine. Regenerative medicine has wide areas of application such as cardiovascular, neurology,...

2014-09-16 23:05:42

Scientists Begin Rallying Around Global Effort to Create a New Liver Washington, D.C. (PRWEB) September 16, 2014 New Organ, a collective initiative for tissue engineering and regenerative medicine, announced today the initial six teams competing for the New Organ Liver Prize, a global prize competition sponsored by the Methuselah Foundation, a biomedical charity. The prize challenge will award $1,000,000 to the first team that creates a regenerative or bioengineered solution that enables...

2014-09-10 16:26:29

SAN DIEGO, Sept. 10, 2014 /PRNewswire/ -- ViaCyte, Inc., a privately held regenerative medicine company developing a stem cell-derived islet replacement therapy for the treatment of diabetes, called VC-01, announced today that it has been selected to receive a $16.6 million Accelerated Development Pathway Award from the California Institute for Regenerative Medicine (CIRM). According to CIRM, the Accelerated Development Awards were created to "provide selected applicants who are...

2014-09-10 16:26:12

DUBLIN, Sept. 10, 2014 /PRNewswire/ -- Research and Markets has announced the addition of the "Regenerative Medicine - Global Strategic Business Report" report to their offering. http://photos.prnewswire.com/prnvar/20130307/600769 This report analyzes the worldwide markets for Regenerative Medicine in US$ Million. The report provides separate comprehensive analytics for the US, Japan, Europe, Asia-Pacific, and Rest of World. Annual estimates and forecasts are provided for the period 2013...


Word of the Day
cacodemon
  • An evil spirit; a devil.
  • A nightmare.
  • In astrology, the twelfth house of a scheme or figure of the heavens: so called from its signifying dreadful things, such as secret enemies, great losses, imprisonment, etc.
'Cacodemon' comes from a Greek term meaning 'evil genius.'
Related